Sfoglia per Autore  

Opzioni
Mostrati risultati da 61 a 80 di 297
Titolo Data di pubblicazione Autore(i) File
Risk minimization activities of centrally authorized products in the EU: a descriptive study 1-gen-2012 Zomerdijk, I. M.; Sayed-Tabatabaei, F. A.; Trifirò, G.; Blackburn, S. C.; Sturkenboom, M. C.; Straus, S. M.
Using electronic healthcare records for drug safety signal detection: a comparative evaluation of statistical methods 1-gen-2012 Schuemie, M.; Coloma, P.; Straatman, H.; Herings, R.; Trifirò, G.; Matthhews, J.; Prieto-Merino, D.; Molokhia, M.; Pedersen, L.; Gini, R.; Innocenti, F.; Mazzaglia, G.; Picelli, G.; Scotti, L.; van der Lei, J.; Sturkenboom, M.
Electronic healthcare databases for active drug safety surveillance: is there enough leverage? 1-gen-2012 Coloma, P. M.; Trifirò, G.; Schuemie, M. J.; Gini, R.; Herings, R.; Hippisley-Cox, J.; Mazzaglia, G.; Picelli, G.; Corrao, G.; Pedersen, L.; van der Lei, J.; Sturkenboom, M.
A nationwide prospective study on prescribing pattern of antidepressant drugs in Italian primary care 1-gen-2012 Trifirò, G.; Tillati, S.; Spina, E.; Ferrajolo, C.; Alacqua, M.; Aguglia, E.; Rizzi, L.; Caputi, A. P.; Cricelli, C.; Samani, F.
The risk of new onset heart failure associated with dopamine agonist use in Parkinson's disease 1-gen-2012 Mokhles, M. M.; Trifirò, G.; Dieleman, J. P.; Haag, M. D.; van Soest, E. M.; Verhamme, K. M.; Mazzaglia, G.; Herings, R.; Luise, C. d.; Ross, D.; Brusselle, G.; Colao, A.; Haverkamp, W.; Schade, R.; Camp, G. v.; Zanettini, R.; Sturkenboom, M. C.
Risk of cardiac valve regurgitation with dopamine agonist use in Parkinson’s disease and hyperprolactinemia: a multi-country, nested case control study 1-gen-2012 Trifirò, G.; Mokhles, Mm; Dieleman, Jp; van Soest, Em; Verhamme, K; Mazzaglia, G; Herings, R; de Luise, C; Ross, D; Brusselle, G; Colao, A; Haverkamp, W; Schade, R; van Camp, G; Zanettini, R; ., Sturkenboom MC
Adverse drug reaction-related hospitalizations in persons aged 55 years and over: a population-based study in The Netherlands 1-gen-2012 Ruiter, R.; Visser, L. E.; Rodenburg, E. M.; Trifirò, G.; Ziere, G.; Stricker, B. H.
Acute cerebellar ataxia following meningococcal group C conjugate vaccination 1-gen-2012 Cutroneo, P; Italiano, D; Trifiro', Gianluca; Tortorella, G; Russo, A; Isola, S; Caputi, Achille; Spina, Edoardo
Adherence to gastroprotection during cyclooxygenase-2 inhibitor use and the risk of upper gastrointestinal events: A population-based study 1-gen-2012 Valkhoff, V. E.; van Soest, E. M.; Mazzaglia, G.; Molokhia, M.; Schade, R.; Trifiro, G.; Goldstein, J. L.; Hernandez-Diaz, S.; Kuipers, E. J.; Sturkenboom, M. C.
Additional risk minimisation measures in the EU - are they eligible for assessment? 1-gen-2013 Zomerdijk, Im; Trifirò, G; Sayed-Tabatabaei, Fa; Sturkenboom, Mc; Straus, Sm
Burden of community-acquired pneumonia in Italian general practice 1-gen-2013 Sterrantino, C; Trifirò, G; Lapi, F; Pasqua, A; Mazzaglia, G; Piccinni, C; Cricelli, C; Rossi, A; Blasi, F
Epidemiology of gout and hyperuricaemia in Italy during the years 2005-2009: a nationwide population-based study 1-gen-2013 Trifiro', G.; Morabito, P.; Cavagna, L.; Ferrajolo, C.; Pecchioli, S.; Simonetti, M.; Bianchini, E.; Medea, G.; Cricelli, C.; Caputi, A. p.; Mazzaglia, G.
Cyclo-oxygenase-2 inhibitors or nonselective NSAIDs plus gastroprotective agents: what to prescribe in daily clinical practice? 1-gen-2013 Masclee, Gm; Valkhoff, Ve; van Soest, Em; Schade, R; Mazzaglia, G; Molokhia, M; Trifirò, G; Goldstein, Jl; Hernández-Díaz, S; Kuipers, Ej; Sturkenboom, Mc
Drug-induced acute myocardial infarction: identifying 'prime suspects' from electronic healthcare records-based surveillance system 1-gen-2013 Coloma, Pm; Schuemie, Mj; Trifirò, G; Furlong, L; van Mulligen, E; Bauer-Mehren, A; Avillach, P; Kors, J; Sanz, F; Mestres, J; Oliveira, Jl; Boyer, S; Helgee, Ea; Molokhia, M; Matthews, J; Prieto-Merino, D; Gini, R; Herings, R; Mazzaglia, G; Picelli, G; Scotti, L; Pedersen, L; van der Lei, J; Sturkenboom, M; EU-ADR, Consortium
Identification of acute myocardial infarction from electronic healthcare records using different disease coding systems: a validation study in three European countries 1-gen-2013 Coloma, Pm; Valkhoff, Ve; Mazzaglia, G; Nielsson, Ms; Pedersen, L; Molokhia, M; Mosseveld, M; Morabito, P; Schuemie, Mj; van der Lei, J; Sturkenboom, M; Trifirò, G; EU-ADR, Consortium
Clinical and economic burden of adverse drug reactions 1-gen-2013 Sultana, J; Cutroneo, P; Trifiro', Gianluca
BRONJ e fattori di rischio: review clinica di sette anni 1-gen-2013 Cavarra, F.; Trifiro, G.; Rosana, M. A.; Nigrone, Vm.; Pisano, M.; Oteri, G.
Harmonization process for the identification of medical events in eight European healthcare databases: the experience from the EU-ADR project 1-gen-2013 Avillach, P.; Coloma, P.; Gini, R.; Schuemie, M.; Mougin, F.; Dufour, J. C.; Mazzaglia, G.; Giaquinto, C.; Fornari, C.; Herings, R.; Molokhia, M.; Pedersen, L.; Fourrier-Réglat, A.; Fieschi, M.; Sturkenboom, M.; van der Lei, J.; Pariente, A.; Trifirò, G.
Overuse of prescription and otc non-steroidal anti-inflammatory drugs in patients with rheumatoid arthritis and osteoarthritis 1-gen-2013 Cavagna, L; Caporali, R; Trifiro', Gianluca; Arcoraci, Vincenzo; Rossi, S; Montecucco, C.
Design and validation of an automated method to detect known adverse drug reactions in MEDLINE: a contribution from the EU-ADR project 1-gen-2013 Avillach, P; Dufour, Jc; Diallo, G; Salvo, F; Joubert, M; Thiessard, F; Mougin, F; Trifiro, G; Fourrier-Reglat, A; Pariente, A; Fieschi, M
Mostrati risultati da 61 a 80 di 297
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile